Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT05271279
What this trial is testing

OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Solid TumorRelapsed/Refractory Lymphoma
Beijing Boren Hospital 2
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Looking for participantsNCT06650566
What this trial is testing

Study of LM-299 in Subjects Advanced Malignant Tumors

Who this might be right for
Malignant Tumors
LaNova Medicines Limited 108
Early research (Phase 1)UnknownNCT05198752
What this trial is testing

Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Stemirna Therapeutics 30
Early research (Phase 1)Study completedNCT02540876
What this trial is testing

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant NeoplasmSolid NeoplasmUnresectable Malignant Neoplasm
University of Chicago 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Early research (Phase 1)Study completedNCT00516438
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Who this might be right for
Malignant Solid Tumors
AstraZeneca 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715281
What this trial is testing

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Who this might be right for
Advanced Rare Malignant Solid NeoplasmRare Malignant Solid NeoplasmRefractory Rare Malignant Solid Neoplasm
National Cancer Institute (NCI) 12
Early research (Phase 1)Ended earlyNCT00801151
What this trial is testing

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Who this might be right for
Malignant Solid Tumour
Institut Claudius Regaud 30
Early research (Phase 1)Study completedNCT01023737
What this trial is testing

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
The University of Texas Health Science Center at San Antonio 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Early research (Phase 1)Study completedNCT00783328
What this trial is testing

PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Pfizer 13
Early research (Phase 1)Active Not RecruitingNCT02389309
What this trial is testing

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Brain NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 14
Not applicableStudy completedNCT04889144
What this trial is testing

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 27
Early research (Phase 1)Study completedNCT01639911
What this trial is testing

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastCNS MalignancyMalignant Neoplasm of Gastrointestinal Tract+4 more
University of Illinois at Chicago 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07122063
What this trial is testing

Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 266
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Not applicableLooking for participantsNCT04495790
What this trial is testing

AIMS Cancer Outcomes Study

Who this might be right for
NeoplasmsNeoplasm MalignantAdvanced Cancer+2 more
Advanced Integrative Medical Science Institute 500
Early research (Phase 1)Study completedNCT01588548
What this trial is testing

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

Who this might be right for
Advanced Solid MalignanciesMalignant Lymphoma
AstraZeneca 43
Next Page